For the readers interested in the stock health of Bunge Limited (BG). It is currently valued at $55.03. When the transactions were called off in the previous session, Stock hit the highs of $55.47, after setting-off with the price of $55.17. Company’s stock value dipped to $54.10 during the trading on the day. When the trading was stopped its value was $54.60.
Recently in News on October 8, 2020, Bunge Limited Schedules Third Quarter 2020 Earnings Release and Conference Call. Bunge Limited (NYSE: BG) will announce its financial results for the third quarter of 2020, on Wednesday, October 28, 2020, prior to the market opening. The company’s management will also host a conference call on the same day at 7:00 a.m. Central Time to discuss the results. A slide presentation to accompany the discussion will be posted on www.bunge.com. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Bunge Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $58.19 on 01/02/20, with the lowest value was $29.00 for the same time period, recorded on 03/19/20.
Bunge Limited (BG) full year performance was -0.22%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bunge Limited shares are logging -5.43% during the 52-week period from high price, and 89.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $29.00 and $58.19.
The company’s shares, operating in the sector of Consumer Defensive managed to top a trading volume set approximately around 1277232 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bunge Limited (BG) recorded performance in the market was -4.38%, having the revenues showcasing 26.88% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.63B, as it employees total of 24000 workers.
Analysts verdict on Bunge Limited (BG)
During the last month, 0 analysts gave the Bunge Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 44.70, with a change in the price was noted +16.01. In a similar fashion, Bunge Limited posted a movement of +41.03% for the period of last 100 days, recording 1,189,830 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BG is recording 1.37 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.90.
Bunge Limited (BG): Technical Analysis
Raw Stochastic average of Bunge Limited in the period of last 50 days is set at 91.64%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 91.64%. In the last 20 days, the company’s Stochastic %K was 92.15% and its Stochastic %D was recorded 93.72%.
Let’s take a glance in the erstwhile performances of Bunge Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -4.38%. Additionally, trading for the stock in the period of the last six months notably improved by 45.58%, alongside a downfall of -0.22% for the period of the last 12 months. The shares increased approximately by 8.03% in the 7-day charts and went down by 20.34% in the period of the last 30 days. Common stock shares were driven by 26.88% during last recorded quarter.